by Chris Matranga | May 31, 2023
Janine Schuurman, Ph.D. is an expert in antibody biology and translational research with a demonstrated history of working in drug discovery and development. Dr. Schuurman is a thought leader and an active Board Member of The Antibody Society, an international,...
by Chris Matranga | May 31, 2023
Tara Arvedson, Ph.D., is Chief Scientific Officer at Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome. Prior to leading the company’s drug discovery efforts as CSO, Dr. Arvedson served as Senior Vice...
by PantheonAdmin | Jun 23, 2022
Dr. Shen has led oncology programs in a variety of pharmaceutical settings for over 15 years through all stages of drug development including IND filings, first-in-human trials, registrational trials, and NDA/BLA filings. While working in oncology clinical development...
by PantheonAdmin | Jun 23, 2022
Carl June maintains a research laboratory that studies various mechanisms of lymphocyte activation that relate to immune tolerance and adoptive immunotherapy for cancer and chronic infection. In 2011, his research team published findings detailing a new...
by PantheonAdmin | Jun 23, 2022
Dr. Joseph Fraietta graduated in 2007 from Drexel University with a degree in Bioscience and Biotechnology. His studies continued at Drexel University College of Medicine, where he received a Ph.D. in Microbiology and Immunology in 2012. His graduate work focused on...
